Gelteq limited closes us$5.2 million initial public offering

New york, oct. 30, 2024 (globe newswire) -- gelteq limited (“gelteq” or the “company”), a global biotechnology company that specializes in the formulation, development, and manufacturing of ingestible gel technology, announced today the closing of its initial public offering of 1,300,000 ordinary shares at a public offering price of us$4.00 per share. the ordinary shares commenced trading on the nasdaq global market on october 29, 2024 under the symbol “gels.”
GELS Ratings Summary
GELS Quant Ranking